Novitium Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NOVITIUM PHARMA, and what generic and branded alternatives to NOVITIUM PHARMA drugs are available?
NOVITIUM PHARMA has forty-seven approved drugs.
Drugs and US Patents for Novitium Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novitium Pharma | PYRIDOSTIGMINE BROMIDE | pyridostigmine bromide | SYRUP;ORAL | 211694-001 | Mar 8, 2019 | AA | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Novitium Pharma | LEVOCARNITINE SF | levocarnitine | SOLUTION;ORAL | 211676-002 | Aug 14, 2019 | AA | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Novitium Pharma | ATENOLOL AND CHLORTHALIDONE | atenolol; chlorthalidone | TABLET;ORAL | 215560-002 | Oct 25, 2021 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.